These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 21576832)

  • 1. The development of chronic kidney disease in Japanese patients with non-alcoholic fatty liver disease.
    Arase Y; Suzuki F; Kobayashi M; Suzuki Y; Kawamura Y; Matsumoto N; Akuta N; Kobayashi M; Sezaki H; Saito S; Hosaka T; Ikeda K; Kumada H; Ohmoto Y; Amakawa K; Tsuji H; Hsieh SD; Kato K; Tanabe M; Ogawa K; Hara S; Kobayashi T
    Intern Med; 2011; 50(10):1081-7. PubMed ID: 21576832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multivariate analysis of risk factors for the development of type 2 diabetes in nonalcoholic fatty liver disease.
    Arase Y; Suzuki F; Ikeda K; Kumada H; Tsuji H; Kobayashi T
    J Gastroenterol; 2009; 44(10):1064-70. PubMed ID: 19533014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FIB-4 Index and Diabetes Mellitus Are Associated with Chronic Kidney Disease in Japanese Patients with Non-Alcoholic Fatty Liver Disease.
    Seko Y; Yano K; Takahashi A; Okishio S; Kataoka S; Okuda K; Mizuno N; Takemura M; Taketani H; Umemura A; Nishikawa T; Yamaguchi K; Moriguchi M; Okanoue T; Itoh Y
    Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31881781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum Gamma-Glutamyltransferase, Daily Alcohol Consumption, and the Risk of Chronic Kidney Disease: The Kansai Healthcare Study.
    Shibata M; Sato KK; Uehara S; Koh H; Oue K; Kambe H; Morimoto M; Hayashi T
    J Epidemiol; 2020 Apr; 30(4):163-169. PubMed ID: 30930374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic dysfunction-associated fatty liver disease predicts new onset of chronic kidney disease better than fatty liver or nonalcoholic fatty liver disease.
    Tanaka M; Mori K; Takahashi S; Higashiura Y; Ohnishi H; Hanawa N; Furuhashi M
    Nephrol Dial Transplant; 2023 Feb; 38(3):700-711. PubMed ID: 35612975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for CKD progression in Japanese patients: findings from the Chronic Kidney Disease Japan Cohort (CKD-JAC) study.
    Inaguma D; Imai E; Takeuchi A; Ohashi Y; Watanabe T; Nitta K; Akizawa T; Matsuo S; Makino H; Hishida A;
    Clin Exp Nephrol; 2017 Jun; 21(3):446-456. PubMed ID: 27412450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonalcoholic fatty liver disease is independently associated with an increased incidence of chronic kidney disease in patients with type 1 diabetes.
    Targher G; Mantovani A; Pichiri I; Mingolla L; Cavalieri V; Mantovani W; Pancheri S; Trombetta M; Zoppini G; Chonchol M; Byrne CD; Bonora E
    Diabetes Care; 2014 Jun; 37(6):1729-36. PubMed ID: 24696459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Large-scale long-term follow-up study of Japanese patients with non-alcoholic Fatty liver disease for the onset of hepatocellular carcinoma.
    Kawamura Y; Arase Y; Ikeda K; Seko Y; Imai N; Hosaka T; Kobayashi M; Saitoh S; Sezaki H; Akuta N; Suzuki F; Suzuki Y; Ohmoto Y; Amakawa K; Tsuji H; Kumada H
    Am J Gastroenterol; 2012 Feb; 107(2):253-61. PubMed ID: 22008893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonalcoholic fatty liver disease predicts chronic kidney disease in nonhypertensive and nondiabetic Korean men.
    Chang Y; Ryu S; Sung E; Woo HY; Oh E; Cha K; Jung E; Kim WS
    Metabolism; 2008 Apr; 57(4):569-76. PubMed ID: 18328362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-alcoholic fatty liver disease and clinical outcomes in chronic kidney disease.
    Chinnadurai R; Ritchie J; Green D; Kalra PA
    Nephrol Dial Transplant; 2019 Mar; 34(3):449-457. PubMed ID: 29390103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Young-onset type 2 diabetes mellitus enhances proteinuria, but not glomerular filtration rate decline: A Japanese cohort study.
    Saito H; Tanabe H; Hirai H; Higa M; Tanaka K; Yamaguchi S; Maimaituxun G; Masuzaki H; Kazama JJ; Shimabukuro M
    J Diabetes Investig; 2024 Oct; 15(10):1444-1456. PubMed ID: 39058327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonalcoholic fatty liver disease increases risk of incident advanced chronic kidney disease: a propensity-matched cohort study.
    Park H; Dawwas GK; Liu X; Nguyen MH
    J Intern Med; 2019 Dec; 286(6):711-722. PubMed ID: 31359543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primacy of lowered baseline glomerular filtration rate as a risk for incident chronic kidney disease: A longitudinal study in Japanese subjects.
    Miyakoshi T; Nakasone Y; Sato Y; Yamauchi K; Hashikura R; Takayama M; Hirabayashi K; Koike H; Moriya T; Aizawa T
    Nephrology (Carlton); 2017 Sep; 22(9):684-689. PubMed ID: 27282755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of cigarette smoking on new-onset of chronic kidney disease in a Japanese population without prior chronic kidney disease: Iki epidemiological study of atherosclerosis and chronic kidney disease (ISSA-CKD).
    Ito K; Maeda T; Tada K; Takahashi K; Yasuno T; Masutani K; Mukoubara S; Arima H; Nakashima H
    Clin Exp Nephrol; 2020 Oct; 24(10):919-926. PubMed ID: 32577942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The fatty liver index as a predictor of incident chronic kidney disease in a 10-year prospective cohort study.
    Huh JH; Kim JY; Choi E; Kim JS; Chang Y; Sung KC
    PLoS One; 2017; 12(7):e0180951. PubMed ID: 28738057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-alcoholic fatty liver disease (NAFLD) is associated with an increased incidence of chronic kidney disease (CKD).
    Roderburg C; Krieg S; Krieg A; Demir M; Luedde T; Kostev K; Loosen SH
    Eur J Med Res; 2023 Apr; 28(1):153. PubMed ID: 37062837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of chronic kidney disease in patients with non-alcoholic fatty liver disease: A cohort study.
    Sinn DH; Kang D; Jang HR; Gu S; Cho SJ; Paik SW; Ryu S; Chang Y; Lazo M; Guallar E; Cho J; Gwak GY
    J Hepatol; 2017 Dec; 67(6):1274-1280. PubMed ID: 28870674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pre-hypertension as a significant predictor of chronic kidney disease in a general population: the Ohasama Study.
    Kanno A; Kikuya M; Ohkubo T; Hashimoto T; Satoh M; Hirose T; Obara T; Metoki H; Inoue R; Asayama K; Shishido Y; Hoshi H; Nakayama M; Totsune K; Satoh H; Sato H; Imai Y
    Nephrol Dial Transplant; 2012 Aug; 27(8):3218-23. PubMed ID: 22510379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-alcoholic fatty liver disease, metabolic goal achievement with incident cardiovascular disease and eGFR-based chronic kidney disease in patients with prediabetes and diabetes.
    Li M; Zhao Z; Qin G; Chen L; Lu J; Huo Y; Chen L; Zeng T; Xu M; Chen Y; Wang T; Wang S; Xu Y; Shi L; Tang X; Su Q; Yu X; Yan L; Wan Q; Chen G; Gao Z; Wang G; Shen F; Luo Z; Zhang Y; Liu C; Wang Y; Hu R; Ye Z; Wu S; Deng H; Yang T; Li Q; Qin Y; Mu Y; Zhao J; Ning G; Bi Y; Xu Y; Wang W
    Metabolism; 2021 Nov; 124():154874. PubMed ID: 34517014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Skipping Breakfast and Progression of Chronic Kidney Disease in the General Japanese Population: The Iki City Epidemiological Study of Atherosclerosis and Chronic Kidney Disease (ISSA-CKD).
    Takahashi K; Inoue Y; Tada K; Hiyamuta H; Ito K; Yasuno T; Sakaguchi T; Katsuki S; Shinohara Y; Nohara C; Okutsu S; Abe M; Satoh A; Kawazoe M; Maeda T; Yoshimura C; Mukoubara S; Arima H; Masutani K
    Kidney Blood Press Res; 2024; 49(1):472-479. PubMed ID: 38852587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.